MRI Features and Their Association With Outcomes in Children With Anti-NMDA Receptor Encephalitis
Authors:
- Grace GombolayGGGrace Gombolay
- J. Nicholas BrentonJBJ. Nicholas Brenton
- Jennifer H. YangJYJennifer H. Yang
- Coral M. StrednyCSCoral M. Stredny
- Ryan KammeyerRKRyan Kammeyer
- Catherine E. OttenCOCatherine E. Otten
- NgocHanh VuNVNgocHanh Vu
- Jonathan D. SantoroJSJonathan D. Santoro
- Karla Robles-LopezKRKarla Robles-Lopez
- Andrew ChristianaACAndrew Christiana
- Claude SteriadeCSClaude Steriade
- Morgan MorrisMMMorgan Morris
Open Access
- 1 July 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 10 (4)
Abstract
Objectives How brain MRI lesions associate with outcomes in pediatric anti-NMDA receptor encephalitis (pNMDARE) is unknown. In this study, we correlate T2-hyperintense MRI brain lesions with clinical outcomes in pNMDARE. Methods This was a multicenter retrospective cohort study from 11 institutions. Children younger than 18 years with pNMDARE were included. One-year outcomes were assessed by the modified Rankin Score (mRS) with good (mRS ≤2) and poor (mRS ≥3) outcomes. Results A total of 175 pNMDARE subjects were included, with 1-year mRS available in 142/175 (81%) and 60/175 (34%) had abnormal brain MRIs. The most common T2-hyperintense lesion locations were frontal, temporal, and parietal. MRI features that predicted poor 1-year outcomes included abnormal MRI, particularly T2 lesions in the frontal and occipital lobes. After adjusting for treatment within 4 weeks of onset, improvement within 4 weeks, and intensive care unit admission, MRI features were no longer associated with poor outcomes, but after multiple imputation for missing data, T2 frontal and occipital lesions associated with poor outcomes. Discussion Abnormal frontal and occipital lesions on MRI may associate with 1-year mRS in pNMDARE. MRI of the brain may be a helpful prognostication tool that should be examined in future studies.Keywords
This publication has 14 references indexed in Scilit:
- Evaluation of the Anti-N-Methyl-D-Aspartate Receptor Encephalitis One-Year Functional Status Score in Predicting Functional Outcomes in Pediatric Patients with Anti-N-Methyl-D-Aspartate Receptor EncephalitisPediatric Neurology, 2021
- International Consensus Recommendations for the Treatment of Pediatric NMDAR Antibody EncephalitisNeurology Neuroimmunology & Neuroinflammation, 2021
- An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and modelsThe Lancet Neurology, 2019
- A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitisNeurology, 2019
- Long-term neuropsychological outcome following pediatric anti-NMDAR encephalitisNeurology, 2018
- Brain MRI Characteristics of Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis and Their Associations with 2-Year Clinical OutcomeAmerican Journal of Neuroradiology, 2018
- A clinical approach to diagnosis of autoimmune encephalitisThe Lancet Neurology, 2016
- Treatment and outcome of children and adolescents with N-methyl-d-aspartate receptor encephalitisJournal of Neurology, 2015
- Overlapping demyelinating syndromes and anti–N‐methyl‐D‐aspartate receptor encephalitisAnnals of Neurology, 2014
- Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort studyThe Lancet Neurology, 2013